...
首页> 外文期刊>Urology >Safety of carbon bead injection for incontinence in patients taking warfarin.
【24h】

Safety of carbon bead injection for incontinence in patients taking warfarin.

机译:碳珠注射液对服用华法令的尿失禁患者的安全性。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: To determine the safety of the use of Durasphere in patients receiving warfarin anticoagulation. METHODS: This case series included patients requiring long-term anticoagulation who also had intrinsic sphincteric deficiency or mixed urinary incontinence, and bladder outlets without hypermobility. All patients, with the exception of the 1 man in the study, were treated under local anesthesia with periurethral carbon bead injections, while receiving therapeutic doses of warfarin. RESULTS: Between 1999 and 2004, 20 such patients received carbon bead injections, on 36 different occasions, during therapeutic warfarin administration. Two complications related to the anticoagulation were encountered, one minor complication of a small periurethral hematoma and the other more severe, with a patient developing urinary retention and intravesical hemorrhage. CONCLUSIONS: In most cases, the injection of carbon beads under local anesthesia in patients receiving therapeutic warfarin anticoagulation can be safely performed without reversal of the anticoagulation.
机译:目的:确定在接受华法林抗凝治疗的患者中使用Durasphere的安全性。方法:该病例系列包括需要长期抗凝治疗的患者,这些患者也有内在括约肌功能不全或混合性尿失禁,以及没有活动过度的膀胱出口。除研究中的一名男性外,所有患者均在接受局部麻醉的情况下接受尿道周碳珠注射,同时接受治疗剂量的华法林治疗。结果:在1999年至2004年之间,在华法林治疗期间,有36种不同情况下有20名此类患者接受了碳珠注射。遇到了两种与抗凝相关的并发症,一种是小尿道周围血肿的轻微并发症,另一种是较严重的,伴有尿retention留和膀胱内出血的患者。结论:在大多数情况下,接受华法林抗凝治疗的患者在局部麻醉下注射碳珠可以安全地进行,而无需逆转抗凝作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号